Medication Guide - 7/30/2021

Medication guides are FDA- approved documents that address issues that are specific to particular drugs, and can help patients avoid serious adverse events (side effects). This database does not include Medication Guides for FDA-approved allergenic or cellular/tissue products (see  FDA Online Label Repository  or DailyMed  for these Medication Guides).  More Drug Name Active Ingredient Form;Route Appl. No. Company Date Vyvanse Lisdexamfetamine Dimesylate CAPSULE;ORAL 021977 TAKEDA PHARMS USA 07/29/2021 Botox Onabotulinumtoxina VIAL; SINGLE-USE 103000 ALLERGAN 07/28/2021 Botox Cosmetic Onabotulinumtoxina VIAL; SINGLE-USE 103000 ALLERGAN 07/28/2021 Nulojix Belatacept INJECTABLE; INJECTION 125288 BRISTOL MYERS SQUIBB 07/28/2021 Soliqua 100/33 Insulin Glargine; Lixisenatide SOLUTION;SUBCUTANEOUS 208673 SANOFI-AVENTIS US 07/28/2021 Idhifa Enasidenib Mesylate TABLET;ORAL 209606 CELGENE CORP 07/26/2021 Keytruda Pembrolizumab POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER 125514 MERCK SHARP DOHME 07/26/2021 Manage Subscriptions  |  Unsubscribe All  |  Help This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA